Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
Conditions
- Antiphospholipid (aPL)-Positive
- Thrombocytopaenia
Interventions
- DRUG: Sirolimus
- DRUG: Placebo
Sponsor
Peking University First Hospital
Collaborators